RVPH

RVPH

USD

Reviva Pharmaceuticals Holdings Inc. Common Stock

$0.553-0.017 (-2.982%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.570

Hoch

$0.595

Tief

$0.530

Volumen

5.53M

Unternehmensfundamentaldaten

Marktkapitalisierung

53.3M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

9.52M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.25Aktuell $0.553Hoch $4.28

Ähnliche Nachrichten

Analyst Upgrades

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals with a Buy and maintains $2 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals with a Buy and lowers the price target from $11 to $4.

Mehr anzeigen
HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4
GlobeNewswire

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet

Mehr anzeigen
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners